GlassScriptPhysician profile
Michael B Van Scoy-Mosher
NPI 1619086568
$3,310.76
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,247 · 2020: $945 · 2023: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $457.07 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $456.11 | 2019-2020 | |
| Genentech USA, INC. | $444.51 | 2019-2020 | |
| Janssen Biotech, INC. | $366.21 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $275.55 | 2019-2020 | |
| Incyte Corporation | $179.27 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $175.33 | 2020 | |
| Sanofi-Aventis U.S. LLC | $132.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $128.07 | 2019-2020 | |
| Celgene Corporation | $127.22 | 2019-2020 | |
| Seagen INC. | $118.50 | 2023 | Tukysa |
| Abbvie INC. | $48.27 | 2019 | |
| Pfizer INC. | $46.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.80 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $44.76 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $38.41 | 2019 | |
| Lilly USA, LLC | $35.76 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $30.77 | 2020 | |
| Medtronic Vascular, INC. | $26.39 | 2019 | |
| Daiichi Sankyo INC. | $24.26 | 2020 | |
| Eisai INC. | $21.11 | 2020 | |
| Edwards Lifesciences Corporation | $19.59 | 2020 | |
| Terumo Bct, INC. | $18.74 | 2020 | |
| Circassia INC. | $17.92 | 2019 | |
| Genzyme Corporation | $15.79 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Van Scoy-Mosher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.